Welcome Address

 

On behalf of the Purine and Pyrimidine Society and the Local Organizing Committee, we are pleased to announce the 16th International Symposium on Purine and Pyrimidine Metabolism in Man will be held June 6-9, 2015 in New York City, U.S.A.

International symposia devoted to the study of human purine metabolism were initiated in 1973 in Tel Aviv, Israel and, with expansion of the focus to include pyrimidine metabolism (1985), were convened every three years. Although sponsorship of the international symposia has traditionally been local and without a sustained organizing body, a European Society for the Study of Purine and Pyrimidine Metabolism in Man (ESSPPMM) was formed in 1987, and has met every two years since, in some years, in conjunction with the international symposium. In the 2003 joint international and European symposium in Egmond aan Zee, The Netherlands, an agreement was reached to merge the activities of the international and) European groups in a new organization called the Purine and Pyrimidine Society (PPS). This decision was approved in 2005 by the ESSPPMM membership at their final meeting in Prague. Because rapid advances in our fields of interest dictate, PPS decided to sponsor biennial symposia, the first of which (called PP07) was held in Chicago, in 2007. Subsequent meetings were held in Stockholm, Sweden (2009); Tokyo, Japan (2011); and Madrid, Spain (2013).

PP15 will provide a special opportunity for basic and clinical researchers to present and discuss recent progress in the understanding of clinical and molecular mechanisms of diseases related to purine and pyrimidine metabolism. These include a myriad of pathologies such as: disorders related to uric acid metabolism; gout; renal lithiasis; enzymopathies, immunodeficiencies, and inflammation related to purine and pyrimidine metabolism; purine and pyrimidine transporters and receptors; as well as purines and pyrimidines in cancer, mitochondrial diseases, and anti-infectious agents. The organizing Committee strives to attract participation by investigators spanning the spectrum from gene and protein structural science and molecular genetics to clinical investigation and therapeutics.

The meeting venue is the Faculty House at Columbia University in New York City. Founded in 1754 as King’s College, Columbia University is one of the oldest institutions of higher education in the United States and is located on Morningside Heights at 116th Street and Broadway. The picturesque Columbia campus features the Low Memorial Library, which overlooks a large plaza that is a popular site for students to gather as well as a popular setting for Hollywood movies. The campus is readily accessible via public transportation or taxis to innumerable other tourist attractions in New York City.

We hope that you will have the chance to attend New York PP15. You will have the opportunity to present your research to your colleagues, and discuss advances and to make new friends. In addition, you are encouraged to find the time to incorporate a pre- or post-conference tour of New York City

 

Sincerely yours,

Michio Hirano, MD

President